Latest News in the pharma Industry

Top Stories

Can yeast rise to the challenge of curing cancer?

Can yeast rise to the challenge of curing cancer?

21 Feb 2017

Modified baker’s yeasts cause an immune response and the production of lymphocyte killers, which detect and eliminate cancerous cells.

Read more 
Turbofer: innovative formulation for iron deficiency

Turbofer: innovative formulation for iron deficiency

16 Feb 2017

NTC Pharma expands its product portfolio with a new food supplement containing iron pyrophosphate microencapsulated in liposomal form, Turbofer orosoluble granules.

Read more 
Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic

Molecule shows ability to thwart pathogens’ genetic resistance to antibiotic

23 Jan 2017

The molecule, which is a PPMO, will likely be ready for testing in humans in about 3 years.

Read more 
Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease

Selonterra publishes novel proprietary mechanism for APOE4 in Alzheimer’s disease

17 Jan 2017

Therapies targeted at this novel mechanism have the potential for disease-modification because they will address the genetic root cause of AD.

Read more 
Ariad to be acquired by Takeda for $5.2 billion

Ariad to be acquired by Takeda for $5.2 billion

9 Jan 2017

Ariad stockholders to receive $24.00 per share in cash.

Read more 
Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic

Mylan launches the first generic for EpiPen Auto-Injector as an authorized generic

16 Dec 2016

Authorized generic offered at more than 50% below wholesale acquisition cost of EpiPen auto-injector.

Read more 
Lonza to acquire Capsugel

Lonza to acquire Capsugel

15 Dec 2016

Acquisition will make Lonza a fully integrated solutions provider in oral delivery technologies and active ingredients to the consumer healthcare and nutrition markets.

Read more 
BMS strengthens capabilities with evolution of its US geographic footprint

BMS strengthens capabilities with evolution of its US geographic footprint

13 Dec 2016

Company will also close its Hopewell, New Jersey site and will not renew its lease at the Lake Union Steam Plant site in Seattle, Washington.

Read more 
Pfizer refutes the findings set out in the CMA decision

Pfizer refutes the findings set out in the CMA decision

8 Dec 2016

Pharma giant says it complied with established competition law.

Read more 
Hopes dashed for new Alzheimer drug

Hopes dashed for new Alzheimer drug

23 Nov 2016

Lilly's solanezumab fails to meet primary endpoint of Phase III study.

Read more 
Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor

Pfizer discontinues global development of bococizumab, its investigational PCSK9 inhibitor

2 Nov 2016

Bococizumab deemed unlikely to provide value to patients, physicians, or shareholders.

Read more 
Fighting cancer with the power of immunity

Fighting cancer with the power of immunity

24 Oct 2016

New treatment elicits two-pronged immune response that destroys tumors in mice.

Read more